Ad Scientiam
PrivateLast Round
VC Round
Nov 5, 2023
Company Overview
Ad Scientiam operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a VC Round in November 2023.
Ad Scientiam is a digital health company that develops and validates digital biomarkers for the continuous monitoring of severe and debilitating chronic diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ad Scientiam Comparables
Compare Ad Scientiam with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Altoida, Inc. | 87% | |
| Koneksa Health | 83% | |
| Neurotrack Technologies, Inc. | 78% |
For institutional investors. Book with your work email.
Ad Scientiam Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 5, 2023 | ||||
| VC Round | Jul 13, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ad Scientiam Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TechLife Capital | VC Round |
| Bpifrance | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 31, 2026
Monthly visitors grew 165% MoM, reaching 961.
- Nov 5, 2023
$5.4M round led by TechLife Capital
For institutional investors. Book with your work email.
Ad Scientiam Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ad Scientiam's valuation, stock price, and market status.
Is Ad Scientiam a public or private company?
Ad Scientiam is a private company.
What is the current stock price of Ad Scientiam?
Ad Scientiam is a private company, so its shares have no public market price. Caplight tracks Ad Scientiam's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ad Scientiam worth (valuation)?
Valuation information for Ad Scientiam is not publicly available.
Can I buy Ad Scientiam stock?
Ad Scientiam shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ad Scientiam's last funding round?
Ad Scientiam's most recent funding round was VC Round on November 5, 2023.
Who are the main investors in Ad Scientiam?
Key investors in Ad Scientiam include TechLife Capital.
Will Ad Scientiam IPO soon?
No public IPO plans have been announced for Ad Scientiam.
How can I track Ad Scientiam secondary market activity?
Caplight tracks bids, offers, and trades in Ad Scientiam's shares on secondary markets.